Cas no 144528-23-4 (1-methylindazol-4-ol)
1-methylindazol-4-ol Chemical and Physical Properties
Names and Identifiers
-
- 1-methyl-1H-Indazol-4-ol
- 1-methyl-2H-indazol-4-one
- 1-methylindazol-4-ol
- 4-Hydroxy-1-methyl-1H-indazole
- AG-C-03328
- CTK8A0179
- INDAZOL-4-OL, 1-METHYL-
- SureCN1082224
- CS-0054264
- SCHEMBL1082224
- FMTRKWLCVGCOIB-UHFFFAOYSA-N
- 144528-23-4
- PS-4791
- DTXSID40441317
- AKOS023556850
- SY065458
- DB-191199
- 1H-Indazol-4-ol, 1-methyl-
- W-205608
- MB10366
- MFCD11869776
-
- MDL: MFCD11869776
- Inchi: 1S/C8H8N2O/c1-10-7-3-2-4-8(11)6(7)5-9-10/h2-5,11H,1H3
- InChI Key: FMTRKWLCVGCOIB-UHFFFAOYSA-N
- SMILES: OC1=CC=CC2=C1C=NN2C
Computed Properties
- Exact Mass: 148.06374
- Monoisotopic Mass: 148.063662883g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 151
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.2
- Topological Polar Surface Area: 38?2
Experimental Properties
- Density: 1.27±0.1 g/cm3 (20 oC 760 Torr),
- Solubility: Slightly soluble (4.1 g/l) (25 o C),
- PSA: 38.05
1-methylindazol-4-ol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM111141-1g |
1-methyl-1H-indazol-4-ol |
144528-23-4 | 95% | 1g |
$660 | 2021-08-06 | |
| Alichem | A269002314-1g |
1-Methyl-1H-indazol-4-ol |
144528-23-4 | 95% | 1g |
1,019.70 USD | 2021-06-01 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-UT126-50mg |
1-methylindazol-4-ol |
144528-23-4 | 98% | 50mg |
330.0CNY | 2021-07-14 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-UT126-200mg |
1-methylindazol-4-ol |
144528-23-4 | 98% | 200mg |
826.0CNY | 2021-07-14 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-UT126-250mg |
1-methylindazol-4-ol |
144528-23-4 | 98% | 250mg |
3020CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-UT126-100mg |
1-methylindazol-4-ol |
144528-23-4 | 98% | 100mg |
1205CNY | 2021-05-07 | |
| TRC | M222075-5mg |
1-METHYL-1H-INDAZOL-4-OL |
144528-23-4 | 5mg |
$ 50.00 | 2022-06-02 | ||
| TRC | M222075-10mg |
1-METHYL-1H-INDAZOL-4-OL |
144528-23-4 | 10mg |
$ 70.00 | 2022-06-02 | ||
| TRC | M222075-50mg |
1-METHYL-1H-INDAZOL-4-OL |
144528-23-4 | 50mg |
$ 250.00 | 2022-06-02 | ||
| Apollo Scientific | OR30842-250mg |
4-Hydroxy-1-methyl-1H-indazole |
144528-23-4 | 250mg |
£23.00 | 2025-02-20 |
1-methylindazol-4-ol Related Literature
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
-
Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
-
Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
-
Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
Additional information on 1-methylindazol-4-ol
Comprehensive Overview of 1-Methylindazol-4-ol (CAS No. 144528-23-4): Properties, Applications, and Research Insights
1-Methylindazol-4-ol (CAS No. 144528-23-4) is a heterocyclic organic compound belonging to the indazole family, characterized by a fused benzene and pyrazole ring system. This compound has garnered significant attention in pharmaceutical and agrochemical research due to its versatile scaffold and potential bioactivity. Its molecular formula, C8H8N2O, and unique structural features make it a valuable intermediate in synthetic chemistry.
The 1-methylindazol-4-ol structure is notable for its hydrogen-bonding capabilities, which enhance its interactions with biological targets. Researchers have explored its role in modulating enzyme inhibition, particularly in kinase and phosphodiesterase pathways, making it relevant to drug discovery projects. Recent studies highlight its potential in addressing neurodegenerative diseases and inflammatory conditions, aligning with current trends in precision medicine.
From a synthetic perspective, CAS No. 144528-23-4 serves as a precursor for N-functionalized indazoles, which are pivotal in designing small-molecule therapeutics. Its regioselective reactivity allows for targeted modifications, enabling the development of highly selective compounds. This property is particularly valuable in cancer research, where structure-activity relationships (SAR) are critical for optimizing efficacy.
In agrochemical applications, 1-methylindazol-4-ol derivatives have shown promise as plant growth regulators and pest control agents. Its low environmental persistence and biodegradability align with the growing demand for sustainable agriculture solutions. Industry reports suggest its potential integration into next-generation crop protection formulations, addressing global food security challenges.
Analytical characterization of 144528-23-4 typically involves HPLC, NMR spectroscopy, and mass spectrometry to ensure purity and structural integrity. The compound’s melting point (reported between 180–185°C) and solubility profile (moderate in polar solvents like DMSO) are key parameters for formulation scientists. These properties are frequently discussed in patent literature and process chemistry forums.
Recent advancements in green chemistry have spurred interest in eco-friendly synthesis routes for 1-methylindazol-4-ol. Catalytic methods using transition metals or organocatalysts are being optimized to reduce waste and energy consumption. Such innovations resonate with the pharmaceutical industry’s sustainability goals, a topic dominating ESG (Environmental, Social, Governance) discussions.
Safety assessments indicate that CAS 144528-23-4 requires standard laboratory handling precautions, including PPE (personal protective equipment) and ventilation controls. While not classified as hazardous under major regulatory frameworks, its toxicological data remains an active area of study, particularly for long-term exposure scenarios.
The commercial availability of 1-methylindazol-4-ol through specialty chemical suppliers has expanded its accessibility for academic and industrial researchers. Pricing trends reflect its niche status, with bulk procurement options gaining traction in contract manufacturing networks. Market analysts project growth in demand, driven by its multi-disciplinary applications.
In conclusion, 1-methylindazol-4-ol (CAS No. 144528-23-4) exemplifies the convergence of medicinal chemistry and material science. Its adaptability to diverse research needs—from biopharmaceuticals to agrochemical innovation—positions it as a compound of enduring scientific and commercial relevance. Future studies may unlock further therapeutic potentials, solidifying its role in cutting-edge R&D.
144528-23-4 (1-methylindazol-4-ol) Related Products
- 874668-60-7(6-hydroxy-1H-Indazole-1-ethanol)
- 13436-48-1(1-methyl-1H-indazole)
- 541539-88-2(5-methoxy-2-methyl-2H-Indazole)
- 756839-14-2(1-Methyl-1H-indazol-5-ol)
- 705927-35-1(1-Methyl-1H-indazol-7-ol)
- 52354-73-1(6-methoxy-2-methyl-2H-Indazole)
- 1159511-41-7(5-Hydroxy-2-methyl-2H-indazole)
- 118933-92-9(1-methyl-1H-Indazol-6-ol)
- 52470-67-4(2-methylindazol-6-ol)
- 1236127-55-1(6-Methoxy-1-methyl-1H-indazole)